How is pharmacogenetics changing clinical trial design for percutaneous coronary intervention?
Mattia GalliDominick J AngiolilloPublished in: Expert review of clinical pharmacology (2023)
Keyphrases
- percutaneous coronary intervention
- clinical trial
- st segment elevation myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- antiplatelet therapy
- coronary artery bypass grafting
- phase ii
- open label
- study protocol
- atrial fibrillation
- coronary artery bypass
- double blind
- left ventricular
- heart failure